These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34109436)

  • 1. Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells.
    Tseng YH; Yang RC; Chiou SS; Shieh TM; Shih YH; Lin PC
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pterocarpanquinone LQB‑118 compound induces apoptosis of cytarabine‑resistant acute myeloid leukemia cells.
    Hancio T; Mazzoccoli L; Guimarães G; Robaina M; Mendonça BDS; Nestal De Moraes G; Monte-Mor BDCR; Mayumi Gutiyama L; De Carvalho LO; Netto CD; Costa PRR; De Faria FCC; Maia RC
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33786613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells.
    Guo Y; Shan Q; Gong Y; Lin J; Shi F; Shi R; Yang X
    Pharmazie; 2014 Mar; 69(3):229-33. PubMed ID: 24716415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
    Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
    Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
    Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
    Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin and tetrahydrocurcumin induce cell death in Ara-C-resistant acute myeloid leukemia.
    Tseng YH; Chiou SS; Weng JP; Lin PC
    Phytother Res; 2019 Apr; 33(4):1199-1207. PubMed ID: 30834607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
    Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
    Sun X; Yang S; Song W
    Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
    Shah K; Mirza S; Desai U; Jain N; Rawal R
    Anticancer Agents Med Chem; 2016; 16(1):128-35. PubMed ID: 26278546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.
    Pan J; Wang Y; Huang S; Mao S; Ling Q; Li C; Li F; Yu M; Huang X; Huang J; Lv Y; Li X; Ye W; Wang H; Wang J; Jin J
    J Mol Med (Berl); 2024 Mar; 102(3):415-433. PubMed ID: 38340163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib enhances chemosensitivity of acute myeloid leukemia hl60 cells to cytarabine by inducing apoptosis.
    Pan Q; Wang J; Jiang X; Yang E; Dong L; Gu K
    J BUON; 2019; 24(1):374-381. PubMed ID: 30941994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.
    Liu LL; Long ZJ; Wang LX; Zheng FM; Fang ZG; Yan M; Xu DF; Chen JJ; Wang SW; Lin DJ; Liu Q
    Mol Cancer Res; 2013 Nov; 11(11):1326-36. PubMed ID: 24008673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
    Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
    Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
    Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
    Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines.
    Ibrahim SM; Bakhashab S; Ilyas AM; Pushparaj PN; Karim S; Khan JA; Abuzenadah AM; Chaudhary AG; Al-Qahtani MH; Ahmed F
    Oncol Rep; 2019 Jun; 41(6):3179-3188. PubMed ID: 30942458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
    Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D
    Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.